Eagle Pharmaceuticals (EGRX) Short Interest Ratio & Short Volume $0.95 +0.05 (+5.56%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Eagle Pharmaceuticals Short Interest DataEagle Pharmaceuticals (EGRX) has a short interest of 371,600 shares, representing 2.90% of the float (the number of shares available for trading by the public). This marks a 6.02% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 43,316 shares to cover all short positions.Current Short Interest371,600 sharesPrevious Short Interest350,500 sharesChange Vs. Previous Month+6.02%Dollar Volume Sold Short$1.39 millionShort Interest Ratio1.7 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares12,990,000 sharesFloat Size12,810,000 sharesShort Percent of Float2.90%Today's Trading Volume12,020 sharesAverage Trading Volume43,316 sharesToday's Volume Vs. Average28% Short Selling Eagle Pharmaceuticals? Sign up to receive the latest short interest report for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEGRX Short Interest Over TimeEGRX Days to Cover Over TimeEGRX Percentage of Float Shorted Over Time Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Eagle Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/2024371,600 shares $1.39 million +6.0%2.9%1.7 $3.73 9/15/2024350,500 shares $1.51 million -17.3%3.1%2.4 $4.31 8/31/2024423,800 shares $2.18 million -12.5%3.7%2.9 $5.14 8/15/2024484,200 shares $1.93 million +14.1%4.2%3.1 $3.98 7/31/2024424,400 shares $2.05 million -44.9%3.7%2.5 $4.82 7/15/2024770,600 shares $4.60 million -16.8%6.7%4.5 $5.97 Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 6/30/2024925,900 shares $5.19 million -6.9%8.1%5.2 $5.60 6/15/2024994,400 shares $3.83 million -7.9%8.7%6.7 $3.85 5/31/20241,080,000 shares $3.75 million -5.3%9.5%7.1 $3.47 5/15/20241,140,000 shares $5.26 million -5.0%10.0%7.8 $4.61 4/30/20241,200,000 shares $4.91 million +1.7%10.5%7.7 $4.09 4/15/20241,180,000 shares $6.14 million -2.5%10.3%5.9 $5.20 3/31/20241,210,000 shares $6.34 million +4.3%10.6%5.3 $5.24 3/15/20241,160,000 shares $7.02 million +4.5%10.2%5 $6.05 2/29/20241,110,000 shares $6.50 million +4.7%9.7%4.3 $5.86 2/15/20241,060,000 shares $6.20 million +33.2%9.3%3.6 $5.85 1/31/2024796,100 shares $4.67 million +10.1%7.0%2.8 $5.86 1/15/2024723,100 shares $3.28 million +3.7%6.4%2.9 $4.53 12/31/2023697,400 shares $3.65 million +3.9%6.2%3.4 $5.23 12/15/2023671,300 shares $3.11 million +13.7%5.9%3.6 $4.63 11/30/2023590,400 shares $3.45 million -0.7%5.2%3.9 $5.85 11/15/2023594,600 shares $5.25 million -3.7%5.2%5.2 $8.83 10/31/2023617,600 shares $8.48 million +2.4%5.5%5.8 $13.73 10/15/2023602,900 shares $8.10 million +12.5%5.3%4.9 $13.43 9/30/2023536,000 shares $8.45 million -23.9%4.7%4.1 $15.77 9/15/2023704,600 shares $11.42 million +9.9%6.2%5.2 $16.21 8/31/2023640,900 shares $10.86 million -6.1%5.7%3.3 $16.95 8/15/2023682,400 shares $11.63 million +4.5%6.0%3.4 $17.04 7/31/2023653,200 shares $13.56 million -4.0%5.7%3.2 $20.76 7/15/2023680,200 shares $12.50 million +14.6%6.0%3.6 $18.37 6/30/2023593,600 shares $11.54 million -26.9%5.2%3.2 $19.44 6/15/2023812,500 shares $15.41 million +18.6%7.1%4.2 $18.96 5/31/2023685,200 shares $14.22 million -1.3%6.0%4.1 $20.75 5/15/2023694,400 shares $14.60 million -3.0%6.1%4.3 $21.03 4/30/2023715,700 shares $20.10 million -5.1%6.3%4.7 $28.08 4/15/2023754,400 shares $22.41 million -19.7%6.7%4.8 $29.71 3/31/2023939,300 shares $26.65 million -7.9%8.3%5.5 $28.37 3/15/20231,020,000 shares $26.27 million +16.4%9.0%6.3 $25.75 2/28/2023876,100 shares $24.53 million +1.0%7.8%6.1 $28.00 2/15/2023867,400 shares $26.73 million -0.8%7.7%6.3 $30.82Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 1/31/2023874,400 shares $29.68 million -9.7%7.7%5.8 $33.94 1/15/2023968,700 shares $31.43 million -2.4%8.6%6.2 $32.45 12/30/2022992,100 shares $29.00 million +63.8%8.8%6.4 $29.23 12/15/2022605,700 shares $17.90 million -27.0%5.4%3.6 $29.55 11/30/2022830,100 shares $30.15 million -9.4%7.3%4.9 $36.32 11/15/2022915,900 shares $33.89 million +0.1%8.1%5.3 $37.00 10/31/2022915,200 shares $28.80 million -6.5%8.1%4.9 $31.47 10/15/2022978,700 shares $27.01 million +8.4%8.5%5.6 $27.60 9/30/2022903,200 shares $23.86 million +28.8%7.8%5.4 $26.42 9/15/2022701,400 shares $21.13 million -17.2%6.1%4.3 $30.12 8/31/2022846,900 shares $27.75 million +3.2%7.4%5.7 $32.77 8/15/2022820,900 shares $29.49 million -18.7%7.2%5.6 $35.92 7/31/20221,010,000 shares $40.10 million +1.0%9.2%7.4 $39.70 7/15/20221,000,000 shares $44.83 million -2.9%9.1%7.5 $44.83 6/30/20221,030,000 shares $45.76 million -7.2%9.4%7.6 $44.43 6/15/20221,110,000 shares $48.33 million +17.4%10.2%8 $43.54 5/31/2022945,600 shares $44.16 million +4.3%8.6%6.8 $46.70 5/15/2022906,800 shares $39.90 million +8.2%8.3%6.8 $44.00 4/30/2022838,200 shares $36.99 million +20.1%7.7%6.4 $44.13 4/15/2022697,800 shares $35.20 million -3.1%6.4%5.5 $50.44 3/31/2022719,800 shares $35.62 million +4.4%N/A5.5 $49.49 3/15/2022689,700 shares $34.69 million +14.0%6.3%5.9 $50.30 2/28/2022604,900 shares $28.67 million -10.2%5.4%4.8 $47.39 2/15/2022673,200 shares $32.15 million +1.1%6.0%5.6 $47.76 1/31/2022665,700 shares $30.58 million +12.4%5.9%5.9 $45.94 1/15/2022592,400 shares $27.97 million +2.3%N/A5.6 $47.21 12/31/2021579,300 shares $29.50 million -1.0%5.2%6 $50.92 12/15/2021585,100 shares $30.60 million -5.5%5.2%5.8 $52.30 11/30/2021618,900 shares $29.51 million -3.3%5.5%7.1 $47.68 11/15/2021639,900 shares $32.62 million -7.1%5.7%6.9 $50.98 10/29/2021689,000 shares $36.08 million -1.7%6.0%7 $52.37 10/15/2021701,000 shares $38.12 million -11.3%6.1%7 $54.38 9/30/2021790,700 shares $44.11 million -4.8%6.9%7.6 $55.78 9/15/2021830,500 shares $43.92 million -3.3%7.3%7.2 $52.88 8/31/2021859,200 shares $45.86 million -6.7%7.5%7.4 $53.37 8/13/2021920,800 shares $44.91 million -5.0%8.1%7.7 $48.77 7/30/2021969,000 shares $45.06 million +4.6%8.5%8.5 $46.50 7/15/2021926,100 shares $43.55 million -3.1%8.1%8.1 $47.02 6/30/2021955,800 shares $40.91 million -7.2%8.4%8.1 $42.80 6/15/20211,030,000 shares $42.73 million -2.8%9.0%9.3 $41.49 5/28/20211,060,000 shares $42.00 million -1.9%9.3%10.1 $39.62 5/14/20211,080,000 shares $43.92 million +2.9%9.4%9.8 $40.67 4/30/20211,050,000 shares $42.98 million -7.9%9.2%9.1 $40.93 4/15/20211,140,000 shares $49.44 million -16.8%N/A0 $43.37 3/31/20211,370,000 shares $56.25 million -2.1%12.2%11.2 $41.06 3/15/20211,400,000 shares $62.97 million No Change12.4%11 $44.98 2/26/20211,400,000 shares $64.09 million +7.7%12.4%10.8 $45.78 2/12/20211,300,000 shares $62.41 million -7.1%11.6%10.7 $48.01 1/29/20211,400,000 shares $65.63 million -2.1%12.4%11.7 $46.88 1/15/20211,430,000 shares $72.54 million -4.0%12.7%11.4 $50.73Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 12/31/20201,490,000 shares $69.29 million No Change13.2%11.5 $46.50 12/15/20201,490,000 shares $68.81 million -0.7%13.2%10.6 $46.18 11/30/20201,500,000 shares $70.97 million -3.9%13.3%10.2 $47.31 11/15/20201,560,000 shares $76.30 million -4.9%13.8%9.6 $48.91 10/30/20201,640,000 shares $75.74 million -12.3%14.5%9.8 $46.18 10/15/20201,870,000 shares $85.03 million -18.0%15.9%10.6 $45.47 9/30/20202,280,000 shares $96.85 million +27.4%19.4%13 $42.48 9/15/20201,790,000 shares $69.24 million -10.5%15.1%10 $38.68 8/31/20202,000,000 shares $79.36 million +1.5%16.9%11.3 $39.68 8/14/20201,970,000 shares $84.65 million -5.3%16.4%11.6 $42.97 7/31/20202,080,000 shares $96.49 million +0.5%15.9%11.9 $46.39 7/15/20202,070,000 shares $100.46 million +3.5%15.8%12.8 $48.53 6/30/20202,000,000 shares $95.96 million +8.7%15.3%12 $47.98 6/15/20201,840,000 shares $81.68 million +1.1%14.0%11.2 $44.39 5/29/20201,820,000 shares $93.29 million +0.6%13.9%10 $51.26 5/15/20201,810,000 shares $90.99 million -0.6%13.8%9.4 $50.27 4/30/20201,820,000 shares $92.78 million -4.2%13.9%9.9 $50.98 4/15/20201,900,000 shares $91.28 million +0.5%14.6%10.4 $48.04 3/31/20201,890,000 shares $97.11 million +1.0%14.5%10.1 $51.38 3/13/20201,871,600 shares $90.81 million +1.7%14.4%7 $48.52 2/28/20201,840,000 shares $71.15 million +2.2%14.1%12.2 $38.67 2/14/20201,800,000 shares $71.24 million -3.7%13.8%13.2 $39.58 1/31/20201,870,000 shares $91.05 million +8.1%14.4%13 $48.69 1/15/20201,730,000 shares $98.37 million +2.4%13.3%12.1 $56.86 12/31/20191,690,000 shares $96.21 million +8.3%13.0%12 $56.93 EGRX Short Interest - Frequently Asked Questions What is Eagle Pharmaceuticals' current short interest? Short interest is the volume of Eagle Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 371,600 shares of EGRX short. 2.90% of Eagle Pharmaceuticals' shares are currently sold short. Learn More on Eagle Pharmaceuticals' current short interest. What is a good short interest ratio for Eagle Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EGRX shares currently have a short interest ratio of 2.0. Learn More on Eagle Pharmaceuticals's short interest ratio. What is a good short interest percentage for Eagle Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.90% of Eagle Pharmaceuticals' floating shares are currently sold short. Is Eagle Pharmaceuticals' short interest increasing or decreasing? Eagle Pharmaceuticals saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 371,600 shares, an increase of 6.0% from the previous total of 350,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eagle Pharmaceuticals' float size? Eagle Pharmaceuticals currently has issued a total of 12,990,000 shares. Some of Eagle Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eagle Pharmaceuticals currently has a public float of 12,810,000 shares. How does Eagle Pharmaceuticals' short interest compare to its competitors? 2.90% of Eagle Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Eagle Pharmaceuticals: Dyadic International, Inc. (0.87%), CalciMedica, Inc. (1.36%), Immix Biopharma, Inc. (2.66%), Actinium Pharmaceuticals, Inc. (6.89%), vTv Therapeutics Inc. (2.24%), SCYNEXIS, Inc. (2.28%), Verrica Pharmaceuticals Inc. (16.06%), OncoCyte Co. (1.47%), IO Biotech, Inc. (0.45%), Achilles Therapeutics plc (0.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short Eagle Pharmaceuticals stock? Short selling EGRX is an investing strategy that aims to generate trading profit from Eagle Pharmaceuticals as its price is falling. EGRX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eagle Pharmaceuticals? A short squeeze for Eagle Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EGRX, which in turn drives the price of the stock up even further. How often is Eagle Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EGRX, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies DYAI Short Squeeze CALC Short Squeeze IMMX Short Squeeze ATNM Short Squeeze VTVT Short Squeeze SCYX Short Squeeze VRCA Short Squeeze OCX Short Squeeze IOBT Short Squeeze ACHL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EGRX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
